Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers

Abstract

Cardiac natriuretic peptides are markedly elevated in the majority of patients with pacemakers. The prognostic significance of BNP and N-ANP in left ventricular dysfunction warrants close follow-up schedules.

Steady-state B-type natriuretic peptide levels in patients with atrial fibrillation of various clinical backgrounds

“…BNP levels were significantly higher in patients with chronic AF than those in patients with paroxysmal AF irrespective of the presence of structural heart disease. Since BNP levels were reported to be elevated in patients Heart Vessels (2012) 27:280-286 281 with pacemakers [10], we excluded those with pacemaker implantation (Table 3, bottom). BNP levels were similar when we excluded the patients with pacemakers.…”

Brain Natriuretic Peptide: Clinical and Research Challenges

“…These conditions include chronic obstructive pulmonary disease, pulmonary hypertension, right ventricular paced rhythm, obesity, renal insufficiency, advanced age, shock from various causes including sepsis, anemia, intracranial pathology, and cirrhosis. 1,[9][10][11][12][13] These conditions limit the ability of clinicians to properly use BNP levels in clinical practice. Previous studies on the value of BNP in diastolic dysfunction have been performed primarily among men.…”

Η Αξία Των Ερωτηματολογίων Στην Καρδιακή Ανεπάρκεια

“…Οι Gwechenberger et al101 βρήκαν πιο στατιστικά σημαντική αλλά παρόμοιας ισχύς συσχέτιση μεταξύ των τιμών του BNP και των βαθμολογιών του MLHF (Γ=0.30, ρθ.01). Βρέθηκε αρνητική συσχέτιση μεταξύ των τιμών του NT-proBNP και του κλάσματος εξώθησης (rs=-0.547, ρ<0.001), το οποίο δείχνει ότι με την εξέλιξη της καρδιακής ανεπάρκειας όσο εκπίπτει το κλάσμα εξώθησης τόσο αυξάνουν τα επίπεδα στο αίμα του νατριουρητικού πεπτιδίου.…”